HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 215 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $56,191,000 | +54.7% | 1,315,654 | -4.8% | 0.34% | -29.3% |
| Q3 2020 | $36,318,000 | +4.8% | 1,381,957 | +6.9% | 0.48% | +81.3% |
| Q2 2020 | $34,669,000 | -99.8% | 1,293,118 | +22.8% | 0.27% | +58.0% |
| Q1 2020 | $17,184,536,000 | -8.0% | 1,052,974 | 0.0% | 0.17% | +35.2% |
| Q4 2019 | $18,669,229,000 | +114210.7% | 1,052,974 | 0.0% | 0.12% | +9.6% |
| Q3 2019 | $16,332,000 | – | 1,052,974 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |